Stuart J. Schnitt, M.D. is the Director of the Division of Anatomic Pathology at Beth Israel Deaconess Medical Center, co-leader of the Dana Farber Harvard Cancer Center Breast Program, a Professor of Pathology at Harvard Medical School and an internationally recognized expert in breast pathology. He did his internship and residency in Anatomic and Clinical Pathology at Beth Israel Hospital in Boston followed by a fellowship in surgical pathology, also at Beth Israel Hospital.

Dr. Schnitt has published over 300 original articles, review articles, editorials, commentaries, and book chapters, primarily in the area of breast diseases. He has authored a popular breast pathology textbook entitled “Biopsy Interpretation of the Breast”, now in its second edition; this book has also been published in Chinese. In addition, he is one of the editors of the 4th Edition of the “World Health Organization Classification of Tumours of the Breast”, published in 2012. He has been cited in multiple editions of “The Best Doctors in America” and “America’s Top Doctors”.

Dr. Schnitt is a Past President of the United States and Canadian Academy of Pathology (2010-2011). He has lectured extensively around the world. His research interests and contributions to our understanding of benign breast diseases and breast cancer have been broad, but have largely focused on risk factors for local recurrence in patients with invasive breast cancer and ductal carcinoma in situ treated with breast conserving therapy, benign breast disease and breast cancer risk, and stromal-epithelial interactions in breast tumor progression.

The United States and Canadian Academy of Pathology Harvey Goldman Master Teacher Award - March 2019 USCAP

The International Society of Breast Pathology-Breast Cancer Research Foundation-Larry Norton, MD Award of Excellence in Breast Pathology  - March 2019 USCAP

President of U.S. & Canadian Academy of Pathology

• A Practical Guide to Solving Diagnostic Problems in Breast, Genitourinary, Liver, Gastrointestinal and Pancreatic-Billiary Pathology
• Breast, GYN and GU: The Essentials of Accurate Surgical Pathologic Diagnosis
• Celebrating the Illustrious Career of Richard L. Kempson: Surgical Pathology of the Breast, Female Genital Tract, Soft Tissue, Head & Neck and Lung
• Contemporary Surgical Pathology of the Breast and Gynecologic Tract
• Hot Topics , New Developments in Pancreatico-Biliary, Head and Neck,Lung and Genitourinary Pathology
• Hot Topics in Surgical Pathology of the Breast, Genitourinary System, Head and Neck and Lungs
• New Developments and Updates in Breast, Endocrine, Genitourinary and Pulmonary Pathology
• New Developments in the Pathology of Women's Cancers: What Every Pathologist Needs to Know
• Pathology of Women's Cancer: Breast and Gynecologic Pathology Update
• Solving Diagnostic Problems in Breast, Head and Neck, Liver and Lung Pathology
• Solving Diagnostic Problems in GI, GU, Head and Neck and Liver Pathology
• Updates in Breast, Lung, Soft Tissue and Pancreatic-Biliary Pathology
• Women's Cancers: Surgical Pathologic, Cytologic, IHC and Molecular Diagnosis of Breast and Genital Tumors

Past Lectures

• Spindle Cell and Vascular Lesions of the Breast (10/13/2022)
• Breast Pathology Virtual Interactive Slide Seminar 2 (10/12/2022)
• The Spectrum of Triple Negative Breast Cancer (10/12/2022)
• Evaluation of Post-Neoadjuvant Therapy Breast Specimens (10/11/2022)
• Breast Pathology Virtual Interactive Slide Seminar 1 (10/10/2022)
• Lobular Carcinoma In Situ and Problematic In Situ Lesions of the Breast (10/10/2022)
• Molecular Testing in the Management of Patients with Breast Cancer (06/27/2019)
• Important Non-Epithelial Lesions of the Breast (06/26/2019)
• The Continuing Dilemma of Ductal Carcinoma In Situ (06/25/2019)
• The Challenge of Evaluating Post-Neoadjuvant Therapy Breast Specimens (06/24/2019)
• Inflammatory and Reactive Lesions of the Breast (06/24/2019)
• Spindle Cell Lesions of the Breast (10/18/2018)
• The Spectrum of Triple Negative Breast Neoplasia (10/17/2018)
• Lobular Carcinoma In Situ and Problematic In Situ Lesions (10/16/2018)
• Contemporary Issues in Breast Lumpectomy Margin Evaluation (10/15/2018)
• Problematic Issues in Breast Core Needle Biopsies (10/15/2018)
• Molecular Testing of Breast Cancer: Current Status and Future Directions (10/19/2017)
• Important Non-Epithelial Lesions of the Breast (10/18/2017)
• Papillary Lesions of the Breast (10/17/2017)
• Inflammatory and Reactive Lesions of the Breast (10/16/2017)
• The Continuing Dilemma of Ductal Carcinoma In Situ (10/16/2017)
• Molecuar Classification of Breast Cancer and Molecular Prognostic Tests (10/20/2016)
• Contemporary View of Lumpectomy Margin Evaluation (10/19/2016)
• Spindle Cell Lesions of the Breast (10/18/2016)
• LCIS and Problematic in situ Breast Lesions (10/17/2016)
• Problematic Issues in Breast Core Needle Biopsy (10/17/2016)
• Molecular Classification of Breast Cancer and Molecular Prognostic Tests (07/21/2015)
• Evaluating Margins of Lumpectomy Speciments: A New Look at an Old Problem (07/21/2015)
• Uncommon Breast Lesions You Don't Want to Miss (07/20/2015)
• Proliferative Breast Lesions: Morphologic Features, Differential Diagnosis and Observer Reproducibility (07/20/2015)
• Spindle Cell Lesions of the Breast (02/21/2014)
• Molecular Classification of Breast Cancer and Molecular Prognostic Tests (02/20/2014)
• Current Controversies in the Management of Lobular Carcinoma in Situ and Problematic in Situ Lesions (02/19/2014)
• Uses and Limitations of Immunohistochemistry in Breast Pathology (02/18/2014)
• Columnar Cell Lesions and Flat Epithelial Atypia (02/17/2014)
• Uses and Limitations of Immunohistochemistry in Breast Pathology (02/24/2012)
• Spindle Cell Lesions of the Breast (02/24/2012)
• Current Controversies in the Management of Lobular Carcinoma in situ and Problematic in situ Lesions (02/22/2012)
• Molecular Classification of Breast Cancer and Molecular Prognostic Tests (02/21/2012)
• Columnar Cell Lesions and Flat Epithelial Atypia (02/20/2012)
• nbn (05/31/2011)